A biopharmaceutical company involved in the discovery.

Advanced Lifestyle Sciences Holdings reports reduction in net reduction for full-year 2009 Advanced Life Sciences Holdings, Inc. , a biopharmaceutical company involved in the discovery, commercialization and advancement of novel medicines in the therapeutic areas of infection, and respiratory diseases oncology, announced its financial outcomes for the fourth one fourth and full year finished December 31 today, 2009. December 31 The net reduction allocable to common shareholders for the three months ended, 2009 was $1 ed drugs .5 million or per share compared to a net loss allocable to common shareholders of $2.8 million or per share for the three months ended December 31, 2008.3 million or per share in comparison to a net loss allocable to common shareholders of $23.0 million or per share for 2008.